Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while UDR Inc. Common Stock trades at $33.96 (market cap $10.91B). The key difference: UDR Inc. Common Stock is the larger of the two by market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| IONS | UDR | |
|---|---|---|
Market Cap | $7.10B | $10.91B |
Volume | 2,027,457 | 3,347,873 |
Sector | Health | Real Estate |
52-Week High | $86.50 | $41.24 |
52-Week Low | $42.38 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | $16.95B |
Dividend Yield | — | 5.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
